Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
NCT ID: NCT02230826
Last Updated: 2025-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2500 participants
OBSERVATIONAL
2014-05-31
2044-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty
NCT05686278
Observational Study to Collect Safety Data and PROMs on Primary THA
NCT06518993
Hip Prospective Study
NCT05956236
Avenir® Cemented Hip Stem - PMCF
NCT03396224
POLARSTEM Retrospective Multicenter Study
NCT02680340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Hip arthroplasty
Patients with Hip implants.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study
* Subjects who agreed for study participation.
Exclusion Criteria
* Subjects with anaesthetic risk class IV or higher
* Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.)
* Contraindications for arthroplasty with a Corin hip devices as per product IFU
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corin
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Goulven Rochcongar, MD
Role: STUDY_CHAIR
University Hospital, Caen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux - Groupe Hospitalier Pellegrin
Bordeaux, , France
clinique Oxford Cannes
Cannes, , France
CH Dunkerque
Dunkirk, , France
Polyclinique Henin Beaumont
Hénin-Beaumont, , France
CHU de Nice
Nice, , France
Centre Hospitalier Régionnal d'Orléans - Site La Source
Orléans, , France
Clinique Arago
Paris, , France
Hôpital de la Croix Saint-Simon
Paris, , France
Hopital privé Saint-Martin
Pessac, , France
Hôpital Provo
Roubaix, , France
Polyclinique St Georges de Didonne
Saint-Georges-de-Didonne, , France
Médipôle Garonne
Toulouse, , France
Hôpital Jean Bernard
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Romain GALMICHE, MD
Role: primary
Régis BERNARD DE DOMPSURE, MD
Role: primary
Antoine MOUTON, MD
Role: primary
François GIRAUD, MD
Role: primary
Christine LAUTRIDOU, MD
Role: primary
Charles BERTON, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1302-T-HIPLTO-RM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.